TY - JOUR
T1 - Current and new challenges in occupational lung diseases
AU - De Matteis, Sara
AU - Heederik, Dick
AU - Burdorf, Alex
AU - Colosio, Claudio
AU - Cullinan, Paul
AU - Henneberger, Paul K
AU - Olsson, Ann
AU - Raynal, Anne
AU - Rooijackers, Jos
AU - Santonen, Tiina
AU - Sastre, Joaquin
AU - Schlünssen, Vivi
AU - Van Tongeren, Martie
AU - Sigsgaard, Torben
AU - European Respiratory Society Environment and Health Committee
N1 - The content of this work is not subject to copyright. Design and branding are copyright ©ERS 2017.
PY - 2017/12/31
Y1 - 2017/12/31
N2 - Occupational lung diseases are an important public health issue and are avoidable through preventive interventions in the workplace. Up-to-date knowledge about changes in exposure to occupational hazards as a result of technological and industrial developments is essential to the design and implementation of efficient and effective workplace preventive measures. New occupational agents with unknown respiratory health effects are constantly introduced to the market and require periodic health surveillance among exposed workers to detect early signs of adverse respiratory effects. In addition, the ageing workforce, many of whom have pre-existing respiratory conditions, poses new challenges in terms of the diagnosis and management of occupational lung diseases. Primary preventive interventions aimed to reduce exposure levels in the workplace remain pivotal for elimination of the occupational lung disease burden. To achieve this goal there is still a clear need for setting standard occupational exposure limits based on transparent evidence-based methodology, in particular for carcinogens and sensitising agents that expose large working populations to risk. The present overview, focused on the occupational lung disease burden in Europe, proposes directions for all parties involved in the prevention of occupational lung disease, from researchers and occupational and respiratory health professionals to workers and employers.
AB - Occupational lung diseases are an important public health issue and are avoidable through preventive interventions in the workplace. Up-to-date knowledge about changes in exposure to occupational hazards as a result of technological and industrial developments is essential to the design and implementation of efficient and effective workplace preventive measures. New occupational agents with unknown respiratory health effects are constantly introduced to the market and require periodic health surveillance among exposed workers to detect early signs of adverse respiratory effects. In addition, the ageing workforce, many of whom have pre-existing respiratory conditions, poses new challenges in terms of the diagnosis and management of occupational lung diseases. Primary preventive interventions aimed to reduce exposure levels in the workplace remain pivotal for elimination of the occupational lung disease burden. To achieve this goal there is still a clear need for setting standard occupational exposure limits based on transparent evidence-based methodology, in particular for carcinogens and sensitising agents that expose large working populations to risk. The present overview, focused on the occupational lung disease burden in Europe, proposes directions for all parties involved in the prevention of occupational lung disease, from researchers and occupational and respiratory health professionals to workers and employers.
U2 - 10.1183/16000617.0080-2017
DO - 10.1183/16000617.0080-2017
M3 - Article
C2 - 29141963
SN - 0905-9180
VL - 26
JO - European Respiratory Review
JF - European Respiratory Review
IS - 146
M1 - 170080
ER -